Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Urologix, Inc.

http://www.urologix.com/

Latest From Urologix, Inc.

Korean COVID-19 Contenders Still Racing Toward Finish Line

Hyundai Bioscience’s niclosamide-based oral antiviral moves into Phase II, joining other Korean COVID-19 treatment candidates in the pivotal trial stages, while SK Bioscience’s Phase III recombinant protein vaccine gears up for global market entry.

South Korea Coronavirus COVID-19

Korean Pharmas Seek Tie-Ups, Support To Enter Pharmerging Markets

Through its latest government-linked project, Korean pharma consortium Kimco aims to speed up industry collaboration and step up technology competitiveness to move into rapidly growing pharmerging markets.

South Korea BioPharmaceutical

Medtech Execs On The Move, April 2015

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device

News Briefs: GE Healthcare Buys Thermo Fisher Research Tools; BD Acquires Alverix

GE Healthcare purchased Thermo Fisher’s research tools for $1 billion. Becton Dickinson acquires point-of-care diagnostic maker Alverix for $40 million. More news briefs.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
UsernamePublicRestriction

Register